TeamHealth Holdings (TMH) Tops Q2 EPS by 1c

Go back to TeamHealth Holdings (TMH) Tops Q2 EPS by 1c

Leerink Partners Remain Bullish on TeamHealth Holdings (TMH) Following 2Q15 Results

August 5, 2015 9:10 AM EDT

Leerink Partners reiterated an Outperform rating and $80.00 price target on Team Health (NYSE: TMH) following 2Q15 report. Net revenue at $878MM beat consensus at $833B. Adjusted EPS at $0.70 beat consensus by 1.4%.

Analyst Ana Gupte commented, "TMH (OP) reported 2Q15 earnings today before market open. Net revenue beat consensus by 5.5% driven acquisitions and new contracts exhibiting sequential and YoY improvement... More

Team Health (TMH) PT Raised to $72 at Piper Jaffray Following IPC Deal

August 5, 2015 9:01 AM EDT

Piper Jaffray analyst Kevin Ellich reiterated an Overweight rating and raised his price target on Team Health (NYSE: TMH) to $72.00 (from $68.00), saying they remain buyers of the stock after the the company announced a definitive agreement to acquire IPCM for $1.6B.

Ellich... More

TeamHealth Holdings (TMH) to Acquire IPC Healthcare (IPCM) in ~$1.6B Deal

August 4, 2015 8:16 AM EDT

TeamHealth Holdings (NYSE: TMH) announced a definitive agreement to acquire IPC Healthcare Inc. ("IPC Healthcare") (Nasdaq: IPCM), a leading national acute hospitalist and post-acute provider organization, in an all-cash transaction with an enterprise value of approximately $1.6 billion or $80.25 per share. The boards of directors of both companies have approved the transaction.

"We are excited to announce this strategic transaction with IPC Healthcare to create the leading physician services organization spanning multiple specialties," said TeamHealth President and Chief Executive Officer, Mike Snow. "Through this combination, TeamHealth... More